By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Enanta Pharmaceuticals, Inc. 

500 Arsenal Street

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-607-0800 Fax: 617-607-0530


SEARCH JOBS


Industry
Pharmaceutical






Company News
Enanta Pharmaceuticals, Inc. Announces European Medicines Agency Validates Marketing Authorization Applications For AbbVie (ABBV)’s Investigational, All-Oral, Interferon-Free Regimen For Genotype 1 Chronic Hepatitis C 6/17/2014 11:31:59 AM
Enanta Pharmaceuticals, Inc. Announces U.S. FDA Grants Priority Review To AbbVie (ABBV) For Investigational, All-Oral, Interferon-Free Regimen For Genotype 1 Chronic Hepatitis C 6/16/2014 10:54:07 AM
Enanta Pharmaceuticals, Inc. To Present At Two Upcoming Investor Conferences 6/11/2014 6:42:08 AM
Enanta Pharmaceuticals, Inc. To Present At Jefferies and Co. 2014 Global Healthcare Conference 5/22/2014 7:46:45 AM
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal Second Quarter Ended March 31, 2014 5/12/2014 7:13:11 AM
Enanta Pharmaceuticals, Inc. Announces The Appointment Of Nathaniel S. Gardiner, J.D. As Senior Vice President And General Counsel 5/12/2014 7:10:44 AM
Enanta Pharmaceuticals, Inc. Announces Submission Of EU Marketing Authorization Applications To European Medicines Agency For All-Oral, Interferon-Free Hepatitis C Regimen Containing ABT-450 5/8/2014 7:59:09 AM
Enanta Pharmaceuticals, Inc. To Present At The 39th Annual Deutsche Bank (DB) Securities Healthcare Conference 4/30/2014 9:12:22 AM
Enanta Pharmaceuticals, Inc. To Host Conference Call To Discuss Financial Results For The Fiscal Second Quarter And Six Months Ended March 31, 2014 4/28/2014 9:24:44 AM
Enanta Pharmaceuticals, Inc. Announces New Drug Application Submission To The FDA For All-Oral, Interferon-Free Hepatitis C Regimen 4/22/2014 8:10:57 AM
1234567
//-->